Heart Disease News and Research

Latest Heart Disease News and Research

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

With sequester day looming, partisan differences become more entrenched

Some news outlets take a hard look at the impact that health programs would feel if the scheduled cuts go forward.

26 Feb 2013

Nanyang Technological University receives Toh Kian Chui Foundation gift for LKCMedicine

Nanyang Technological University (NTU) has received a gift of S$20 million from the Toh Kian Chui Foundation to the Lee Kong Chian School of Medicine (LKCMedicine).

26 Feb 2013

Researchers create high resolution atlas of the heart with 3D images taken from 138 people

Researchers at Pompeu Fabra University (Spain) have created a high resolution atlas of the heart with 3D images taken from 138 people.

26 Feb 2013

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

One way to contain health care spending is to get patients involved in weighing costs of treatment options with their doctors. Researchers recruited 211 medically insured participants to assess their willingness to consider costs when choosing treatments. The authors found that participants generally "preferred better care, even when the relative benefit it offered was marginal, and even when told that the second-best choice still met the threshold of 'good enough' care from a clinician's perspective.

26 Feb 2013

Henry Ford Hospital scientists to research into hypertension and tissue and organ damage

A senior staff scientist and his team at Henry Ford Hospital have been awarded a five-year, $12.4 million grant by the National Institutes of Health for their research into the damaging effects of high blood pressure on various organs in the body.

26 Feb 2013

Robert Wood Johnson Medical Group physicians appear on the Best Doctors in America List

Eighty-five physicians affiliated with The Robert Wood Johnson Medical Group, the faculty practice of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, appear on the Best Doctors in America List for 2013.

26 Feb 2013

Study explores effects of mindfulness and integrated self-knowledge in treating heart disease

With heart disease one of the world's very biggest killers, new approaches to prevention and treatment are always welcome. In fact, most heart disease can be prevented by changes in people's behaviour and attitudes. The same holds true for the effective treatment of those who have already developed the disease.

26 Feb 2013

BIOTRONIK receives FDA approval for Lumax 740 DX System

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System.

26 Feb 2013

LINX device may help relieve chronic heartburn symptoms

Clinical trial results published in the New England Journal of Medicine this week offer additional evidence that a new device may help relieve chronic heartburn symptoms that standard treatment cannot. The Keck Medical Center of USC was one of 14 U.S. and European medical centers to test the device prior to its March 2012 approval by the U.S. Food and Drug Administration.

26 Feb 2013

LabCorp introduces GeneSeq: Carido for familial cardiac disease

Laboratory Corporation of America Holdings today announced it has launched its clinical next generation sequencing assay, GeneSeq: Cardio for genetic causes of familial cardiac disease.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

Multi-dimensional physical activity assessment recommended

Research suggests that assessment of physical activity level should evaluate a person’s overall level of moderate or vigorous activity as well as their amount of sedentary time to get an accurate estimate.

25 Feb 2013

WOEST supports clopidogrel only in PCI patients on anticoagulation

Publication of the WOEST trial results reaffirm the study’s major finding that antiplatelet therapy with clopidogrel alone is preferable to the use of both aspirin and clopidogrel in patients undergoing percutaneous coronary intervention who are receiving oral anticoagulant therapy.

25 Feb 2013

Antioxidant boosts liver transplant outcomes

Infusion of N-acetylcysteine in liver donors can significantly improve the outcome of transplantation, research shows.

25 Feb 2013

CT angiography uncovers cardiovascular disease risk

Computed tomography angiography can warn of the likelihood for major adverse cardiovascular events in patients suspected of having coronary artery disease in the absence of medically modifiable risk factors, research shows.

25 Feb 2013

Mental health risk increased in children with atopic dermatitis

Results from a US study suggest that children with atopic dermatitis (AD) are at significantly increased risk for mental health disorders.

25 Feb 2013

CHADS scores possibilities extend beyond atrial fibrillation

The CHADS-based risk scores can predict long-term vascular outcomes and mortality in patients with stroke who do not have atrial fibrillation, research suggests.

25 Feb 2013

Community health team improves diabetes control in Polynesian community

A team of community health workers has been able to improve control of Type 2 diabetes in a group of individuals from American Samoa – a medically underserved territory with a high prevalence of obesity, diabetes, and other cardiovascular risk factors, report researchers.

25 Feb 2013

Heart Disease News and Research

Latest Heart Disease News and Research

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

With sequester day looming, partisan differences become more entrenched

Nanyang Technological University receives Toh Kian Chui Foundation gift for LKCMedicine

Researchers create high resolution atlas of the heart with 3D images taken from 138 people

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

Henry Ford Hospital scientists to research into hypertension and tissue and organ damage

Robert Wood Johnson Medical Group physicians appear on the Best Doctors in America List

Study explores effects of mindfulness and integrated self-knowledge in treating heart disease

BIOTRONIK receives FDA approval for Lumax 740 DX System

LINX device may help relieve chronic heartburn symptoms

LabCorp introduces GeneSeq: Carido for familial cardiac disease

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

Multi-dimensional physical activity assessment recommended

WOEST supports clopidogrel only in PCI patients on anticoagulation

Antioxidant boosts liver transplant outcomes

CT angiography uncovers cardiovascular disease risk

Mental health risk increased in children with atopic dermatitis

CHADS scores possibilities extend beyond atrial fibrillation

Community health team improves diabetes control in Polynesian community

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in